Neurological Biomarkers Market Size, Share & Trends Report

Neurological Biomarkers Market Size, Share & Trends Analysis Report By Application (Alzheimer's, Parkinson's), By Type (Genomic, Proteomic), By End-use, By Region, And Segment Forecasts, 2021 - 2028

  • Report ID: GVR-3-68038-823-7
  • Number of Pages: 120
  • Format: Electronic (PDF)
  • Historical Range: 2017 - 2019
  • Industry: Healthcare

Market segmentation

  • Neurological Biomarkers Type Outlook (Revenue, USD Million, 2017 - 2028)
    • Genomic
    • Proteomic
    • Metabolomic
    • Imaging
    • Others
  • Neurological Biomarkers Application Outlook (Revenue, USD Million, 2017 - 2028)
    • Alzheimer's Disease
    • Parkinson's Disease
    • Multiple Sclerosis
    • Autism Spectrum Disorder
    • Others
  • Neurological Biomarkers End-use Outlook (Revenue, USD Million, 2017 - 2028)
    • Hospital & Hospital Laboratories
    • Independent Clinical Diagnostic Centers
    • Research Organizations and Others
  • Neurological Biomarkers Regional Outlook (Revenue, USD Million, 2017 - 2028)
    • North America
      • North America Neurological Biomarkers Market, By Type
        • Genomic
        • Proteomic
        • Metabolomic
        • Imaging
        • Others
      • North America Neurological Biomarkers Market, By Application
        • Alzheimer's Disease
        • Parkinson's Disease
        • Multiple Sclerosis
        • Autism Spectrum Disorder
        • Others
      • North America Neurological Biomarkers Market, By End Use
        • Hospital & Hospital Laboratories
        • Independent clinical diagnostic centers
        • Research Organizations and Others
      • The U.S.
        • The U.S. Neurological Biomarkers Market, By Type
          • Genomic
          • Proteomic
          • Metabolomic
          • Imaging
          • Others
        • The U.S. Neurological Biomarkers Market, By Application
          • Alzheimer's Disease
          • Parkinson's Disease
          • Multiple Sclerosis
          • Autism Spectrum Disorder
          • Others
        • The U.S. Neurological Biomarkers Market, By End Use
          • Hospital & Hospital Laboratories
          • Independent clinical diagnostic centers
          • Research Organizations and Others
      • Canada
        • Canada Neurological Biomarkers Market, By Type
          • Genomic
          • Proteomic
          • Metabolomic
          • Imaging
          • Others
        • Canada Neurological Biomarkers Market, By Application
          • Alzheimer's Disease
          • Parkinson's Disease
          • Multiple Sclerosis
          • Autism Spectrum Disorder
          • Others
        • Canada Neurological Biomarkers Market, By End Use
          • Hospital & Hospital Laboratories
          • Independent clinical diagnostic centers
          • Research Organizations and Others
    • Europe
      • Europe Neurological Biomarkers Market, By Type
        • Genomic
        • Proteomic
        • Metabolomic
        • Imaging
        • Others
      • Europe Neurological Biomarkers Market, By Application
        • Alzheimer's Disease
        • Parkinson's Disease
        • Multiple Sclerosis
        • Autism Spectrum Disorder
        • Others
      • Europe Neurological Biomarkers Market, By End Use
        • Hospital & Hospital Laboratories
        • Independent clinical diagnostic centers
        • Research Organizations and Others
      • The U.K.
        • The U.K. Neurological Biomarkers Market, By Type
          • Genomic
          • Proteomic
          • Metabolomic
          • Imaging
          • Others
        • The U.K. Neurological Biomarkers Market, By Application
          • Alzheimer's Disease
          • Parkinson's Disease
          • Multiple Sclerosis
          • Autism Spectrum Disorder
          • Others
        • The U.K. Neurological Biomarkers Market, By End Use
          • Hospital & Hospital Laboratories
          • Independent clinical diagnostic centers
          • Research Organizations and Others
      • Germany
        • Germany Neurological Biomarkers Market, By Type
          • Genomic
          • Proteomic
          • Metabolomic
          • Imaging
          • Others
        • Germany Neurological Biomarkers Market, By Application
          • Alzheimer's Disease
          • Parkinson's Disease
          • Multiple Sclerosis
          • Autism Spectrum Disorder
          • Others
        • Germany Neurological Biomarkers Market, By End Use
          • Hospital & Hospital Laboratories
          • Independent clinical diagnostic centers
          • Research Organizations and Others
      • France
        • France Neurological Biomarkers Market, By Type
          • Genomic
          • Proteomic
          • Metabolomic
          • Imaging
          • Others
        • France Neurological Biomarkers Market, By Application
          • Alzheimer's Disease
          • Parkinson's Disease
          • Multiple Sclerosis
          • Autism Spectrum Disorder
          • Others
        • France Neurological Biomarkers Market, By End Use
          • Hospital & Hospital Laboratories
          • Independent clinical diagnostic centers
          • Research Organizations and Others
      • Spain
        • Spain Neurological Biomarkers Market, By Type
          • Genomic
          • Proteomic
          • Metabolomic
          • Imaging
          • Others
        • Spain Neurological Biomarkers Market, By Application
          • Alzheimer's Disease
          • Parkinson's Disease
          • Multiple Sclerosis
          • Autism Spectrum Disorder
          • Others
        • Spain Neurological Biomarkers Market, By End Use
          • Hospital & Hospital Laboratories
          • Independent clinical diagnostic centers
          • Research Organizations and Others
      • Italy
        • Italy Neurological Biomarkers Market, By Type
          • Genomic
          • Proteomic
          • Metabolomic
          • Imaging
          • Others
        • Italy Neurological Biomarkers Market, By Application
          • Alzheimer's Disease
          • Parkinson's Disease
          • Multiple Sclerosis
          • Autism Spectrum Disorder
          • Others
        • Italy Neurological Biomarkers Market, By End Use
          • Hospital & Hospital Laboratories
          • Independent clinical diagnostic centers
          • Research Organizations and Others
    • Asia Pacific
      • Asia Pacific Neurological Biomarkers Market, By Type
        • Genomic
        • Proteomic
        • Metabolomic
        • Imaging
        • Others
      • Asia Pacific Neurological Biomarkers Market, By Application
        • Alzheimer's Disease
        • Parkinson's Disease
        • Multiple Sclerosis
        • Autism Spectrum Disorder
        • Others
      • Asia Pacific Neurological Biomarkers Market, By End Use
        • Hospital & Hospital Laboratories
        • Independent clinical diagnostic centers
        • Research Organizations and Others
      • Japan
        • Japan Neurological Biomarkers Market, By Type
          • Genomic
          • Proteomic
          • Metabolomic
          • Imaging
          • Others
        • Japan Neurological Biomarkers Market, By Application
          • Alzheimer's Disease
          • Parkinson's Disease
          • Multiple Sclerosis
          • Autism Spectrum Disorder
          • Others
        • Japan Neurological Biomarkers Market, By End Use
          • Hospital & Hospital Laboratories
          • Independent clinical diagnostic centers
          • Research Organizations and Others
      • China
        • China Neurological Biomarkers Market, By Type
          • Genomic
          • Proteomic
          • Metabolomic
          • Imaging
          • Others
        • China Neurological Biomarkers Market, By Application
          • Alzheimer's Disease
          • Parkinson's Disease
          • Multiple Sclerosis
          • Autism Spectrum Disorder
          • Others
        • China Neurological Biomarkers Market, By End Use
          • Hospital & Hospital Laboratories
          • Independent clinical diagnostic centers
          • Research Organizations and Others
      • India
        • India Neurological Biomarkers Market, By Type
          • Genomic
          • Proteomic
          • Metabolomic
          • Imaging
          • Others
        • India Neurological Biomarkers Market, By Application
          • Alzheimer's Disease
          • Parkinson's Disease
          • Multiple Sclerosis
          • Autism Spectrum Disorder
          • Others
        • India Neurological Biomarkers Market, By End Use
          • Hospital & Hospital Laboratories
          • Independent clinical diagnostic centers
          • Research Organizations and Others
      • South Korea
        • South Korea Neurological Biomarkers Market, By Type
          • Genomic
          • Proteomic
          • Metabolomic
          • Imaging
          • Others
        • South Korea Neurological Biomarkers Market, By Application
          • Alzheimer's Disease
          • Parkinson's Disease
          • Multiple Sclerosis
          • Autism Spectrum Disorder
          • Others
        • South Korea Neurological Biomarkers Market, By End Use
          • Hospital & Hospital Laboratories
          • Independent clinical diagnostic centers
          • Research Organizations and Others
      • Australia
        • Australia Neurological Biomarkers Market, By Type
          • Genomic
          • Proteomic
          • Metabolomic
          • Imaging
          • Others
        • Australia Neurological Biomarkers Market, By Application
          • Alzheimer's Disease
          • Parkinson's Disease
          • Multiple Sclerosis
          • Autism Spectrum Disorder
          • Others
        • Australia Neurological Biomarkers Market, By End Use
          • Hospital & Hospital Laboratories
          • Independent clinical diagnostic centers
          • Research Organizations and Others
    • Latin America
      • Latin America Neurological Biomarkers Market, By Type
        • Genomic
        • Proteomic
        • Metabolomic
        • Imaging
        • Others
      • Latin Americaa Neurological Biomarkers Market, By Application
        • Alzheimer's Disease
        • Parkinson's Disease
        • Multiple Sclerosis
        • Autism Spectrum Disorder
        • Others
      • Latin America Neurological Biomarkers Market, By End Use
        • Hospital & Hospital Laboratories
        • Independent clinical diagnostic centers
        • Research Organizations and Others
      • Brazil
        • Brazil Neurological Biomarkers Market, By Type
          • Genomic
          • Proteomic
          • Metabolomic
          • Imaging
          • Others
        • Brazil Neurological Biomarkers Market, By Application
          • Alzheimer's Disease
          • Parkinson's Disease
          • Multiple Sclerosis
          • Autism Spectrum Disorder
          • Others
        • Brazil Neurological Biomarkers Market, By End Use
          • Hospital & Hospital Laboratories
          • Independent clinical diagnostic centers
          • Research Organizations and Others
      • Mexico
        • Mexico Neurological Biomarkers Market, By Type
          • Genomic
          • Proteomic
          • Metabolomic
          • Imaging
          • Others
        • Mexico Neurological Biomarkers Market, By Application
          • Alzheimer's Disease
          • Parkinson's Disease
          • Multiple Sclerosis
          • Autism Spectrum Disorder
          • Others
        • Mexico Neurological Biomarkers Market, By End Use
          • Hospital & Hospital Laboratories
          • Independent clinical diagnostic centers
          • Research Organizations and Others
      • Argentina
        • Argentina Neurological Biomarkers Market, By Type
          • Genomic
          • Proteomic
          • Metabolomic
          • Imaging
          • Others
        • Argentina Neurological Biomarkers Market, By Application
          • Alzheimer's Disease
          • Parkinson's Disease
          • Multiple Sclerosis
          • Autism Spectrum Disorder
          • Others
        • Argentina Neurological Biomarkers Market, By End Use
          • Hospital & Hospital Laboratories
          • Independent clinical diagnostic centers
          • Research Organizations and Others
    • Middle East & Africa
      • Middle East & Africa Neurological Biomarkers Market, By Type
        • Genomic
        • Proteomic
        • Metabolomic
        • Imaging
        • Others
      • Middle East & Africa Neurological Biomarkers Market, By Application
        • Alzheimer's Disease
        • Parkinson's Disease
        • Multiple Sclerosis
        • Autism Spectrum Disorder
        • Others
      • Middle East & Africa Neurological Biomarkers Market, By End Use
        • Hospital & Hospital Laboratories
        • Independent clinical diagnostic centers
        • Research Organizations and Others
      • South Africa
        • South Africa Neurological Biomarkers Market, By Type
          • Genomic
          • Proteomic
          • Metabolomic
          • Imaging
          • Others
        • South Africa Neurological Biomarkers Market, By Application
          • Alzheimer's Disease
          • Parkinson's Disease
          • Multiple Sclerosis
          • Autism Spectrum Disorder
          • Others
        • South Africa Neurological Biomarkers Market, By End Use
          • Hospital & Hospital Laboratories
          • Independent clinical diagnostic centers
          • Research Organizations and Others
      • Saudi Arabia
        • Saudi Arabia Neurological Biomarkers Market, By Type
          • Genomic
          • Proteomic
          • Metabolomic
          • Imaging
          • Others
        • Saudi Arabia Neurological Biomarkers Market, By Application
          • Alzheimer's Disease
          • Parkinson's Disease
          • Multiple Sclerosis
          • Autism Spectrum Disorder
          • Others
        • Saudi Arabia Neurological Biomarkers Market, By End Use
          • Hospital & Hospital Laboratories
          • Independent clinical diagnostic centers
          • Research Organizations and Others
      • UAE
        • UAE Neurological Biomarkers Market, By Type
          • Genomic
          • Proteomic
          • Metabolomic
          • Imaging
          • Others
        • UAE Neurological Biomarkers Market, By Application
          • Alzheimer's Disease
          • Parkinson's Disease
          • Multiple Sclerosis
          • Autism Spectrum Disorder
          • Others
        • UAE Neurological Biomarkers Market, By End Use
          • Hospital & Hospital Laboratories
          • Independent clinical diagnostic centers
          • Research Organizations and Others

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2017 to 2028
  • Market estimates and forecast for product segments up to 2028
  • Regional market size and forecast for product segments up to 2028
  • Market estimates and forecast for application segments up to 2028
  • Regional market size and forecast for application segments up to 2028
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon gvr sidebar D&B icon gvr sidebar

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.